HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manfredi Ponente Selected Research

Tretinoin (Retinoic Acid)

8/2015Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARĪ± and PLZF-RARĪ±-Driven Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manfredi Ponente Research Topics

Disease

2Neoplasms (Cancer)
01/2017 - 04/2016
2Leukemia
01/2017 - 08/2015
2Hypoxia (Hypoxemia)
04/2016 - 08/2015
1Neoplasm Metastasis (Metastasis)
01/2017
1Hematologic Neoplasms (Hematological Malignancy)
04/2016
1Acute Promyelocytic Leukemia
08/2015

Drug/Important Bio-Agent (IBA)

2Arsenic Trioxide (Trisenox)FDA Link
01/2017 - 08/2015
1Transcription Factors (Transcription Factor)IBA
04/2016
1EZN-2208IBA
08/2015
1Tretinoin (Retinoic Acid)FDA LinkGeneric
08/2015
1Proteins (Proteins, Gene)FDA Link
08/2015

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2017
1Therapeutics
08/2015